These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10709911)

  • 1. The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activation.
    Liang JF; Li Y; Yang VC
    Thromb Res; 2000 Mar; 97(5):349-58. PubMed ID: 10709911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.
    Andrade-Gordon P; Strickland S
    Biochemistry; 1986 Jul; 25(14):4033-40. PubMed ID: 2943315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of fucoidan, heparin and cyanogen bromide-fibrinogen on the activation of human glutamic-plasminogen by tissue plasminogen activator.
    Bell J; Duhon S; Doctor VM
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):229-34. PubMed ID: 12695744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of polysaccharides on plasminogen activation by single chain-and two chain-tissue plasminogen activator.
    Kawamura H; Watanabe I; Urano T; Takada Y; Takada A
    Thromb Res; 1991 Jun; 62(5):481-90. PubMed ID: 1654600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin oligosaccharides enhance tissue-type plasminogen activator: a correlation between oligosaccharide length and stimulation of plasminogen activation.
    Edelberg JM; Conrad HE; Pizzo SV
    Biochemistry; 1991 Nov; 30(45):10999-1003. PubMed ID: 1932024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic analysis of the effects of heparin and lipoproteins on tissue plasminogen activator mediated plasminogen activation.
    Edelberg JM; Pizzo SV
    Biochemistry; 1990 Jun; 29(25):5906-11. PubMed ID: 2143417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1. The effects of fibrinogen, heparin, vitronectin, and lipoprotein(a).
    Edelberg JM; Reilly CF; Pizzo SV
    J Biol Chem; 1991 Apr; 266(12):7488-93. PubMed ID: 1708387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the binding sites of porcine tissue-type plasminogen activator and plasminogen to heparin.
    Soeda S; Kakiki M; Shimeno H; Nagamatsu A
    Biochim Biophys Acta; 1987 Dec; 916(3):279-87. PubMed ID: 3120775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-affinity heparin stimulates the inactivation of plasminogen activator inhibitor-1 by thrombin.
    Patston PA; Schapira M
    Blood; 1994 Aug; 84(4):1164-72. PubMed ID: 8049432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the mechanism of action of heparin and related substances on the fibrinolytic system: relationship between plasminogen activators and heparin.
    Pâques EP; Stöhr HA; Heimburger N
    Thromb Res; 1986 Jun; 42(6):797-807. PubMed ID: 3088755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionic modulation of the effects of heparin on plasminogen activation by tissue plasminogen activator: the effects of ionic strength, divalent cations, and chloride.
    Young TN; Edelberg JM; Stack S; Pizzo SV
    Arch Biochem Biophys; 1992 Aug; 296(2):530-8. PubMed ID: 1385938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator.
    Edelberg JM; Gonzalez-Gronow M; Pizzo SV
    Thromb Res; 1990 Jan; 57(1):155-62. PubMed ID: 2137266
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA.
    Nishino T; Yamauchi T; Horie M; Nagumo T; Suzuki H
    Thromb Res; 2000 Sep; 99(6):623-34. PubMed ID: 10974349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen and tissue plasminogen activator interact with antithrombin III.
    Dudani AK
    Thromb Res; 2000 Sep; 99(6):635-41. PubMed ID: 10974350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the stimulatory effect of native fucoidan, highly sulfated fucoidan and heparin on plasminogen activation by tissue plasminogen activator: the role of chloride.
    Lang D; Williams T; Phillips A; Doctor VM
    Eur J Drug Metab Pharmacokinet; 2004; 29(4):269-75. PubMed ID: 15726889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregated, conformationally changed fibrinogen exposes the stimulating sites for t-PA-catalysed plasminogen activation.
    Haddeland U; Sletten K; Bennick A; Nieuwenhuizen W; Brosstad F
    Thromb Haemost; 1996 Feb; 75(2):326-31. PubMed ID: 8815585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of reteplase with heparin. A comparison between reteplase and alteplase.
    Rijken DC; Jie AF
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):561-6. PubMed ID: 8874867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of heparan sulfate analogue or other sulfated polysaccharides on the activation of plasminogen by t-PA or u-PA.
    Takada Y; Urano T; Takada A
    Thromb Res; 1994 Mar; 73(5):301-11. PubMed ID: 8016815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and characterization of positively charged tPA as a prodrug using heparin/protamine-based drug delivery system.
    Liang JF; Li YT; Connell ME; Yang VC
    AAPS PharmSci; 2000; 2(1):E7. PubMed ID: 11741223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.